Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects.
about
The Host's Reply to Candida BiofilmNew insights on the development of fungal vaccines: from immunity to recent challengesTreatment of vaginal candidiasis for the prevention of preterm birth: a systematic review and meta-analysisExperimental Models of Vaginal Candidiasis and Their Relevance to Human CandidiasisHighlights Regarding Host Predisposing Factors to Recurrent Vulvovaginal Candidiasis: Chronic Stress and Reduced Antioxidant CapacityExamination of the Microbial Spectrum in the Etiology of Erythema Nodosum: A Retrospective Descriptive Study.Induction of caspase-11 by aspartyl proteinases of Candida albicans and implication in promoting inflammatory response.Secretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in Mice.In Vitro Activity of Tea Tree Oil Vaginal Suppositories against Candida spp. and Probiotic Vaginal Microbiota.Effect of norfloxacin therapy for acute, uncomplicated lower urinary tract infection on vaginal Candida prevalence.Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.Aspartyl Proteinases of Eukaryotic Microbial Pathogens: From Eating to HeatingSkin Immunity to Candida albicans.Antimicrobial Compounds Produced by Vaginal Lactobacillus crispatus Are Able to Strongly Inhibit Candida albicans Growth, Hyphal Formation and Regulate Virulence-related Gene Expressions.Antimicrobial activity of Buchenavia tetraphylla against Candida albicans strains isolated from vaginal secretions.Contribution of TLR2 pathway in the pathogenesis of vulvovaginal candidiasis.Efficacy of Histatin5 in a murine model of vulvovaginal candidiasis caused by Candida albicans.The burden of serious human fungal infections in Brazil.NLRP3 inflammasome is a key player in human vulvovaginal disease caused by Candida albicans.A survey on cellular RNA editing activity in response to Candida albicans infections.Effectiveness of Ageratina pichinchensis Extract in Patients with Vulvovaginal Candidiasis. A Randomized, Double-Blind, and Controlled Pilot Study.Synthesis and Biological Evaluation of 2H-Indazole Derivatives: Towards Antimicrobial and Anti-Inflammatory Dual Agents.Experimental models of vaginal candidiasis and inflammation.Mannose-Binding Lectin: A Potential Therapeutic Candidate against Candida Infection.Mannose-Binding Lectin Gene Polymorphism and Its Association with Susceptibility to Recurrent Vulvovaginal Candidiasis.Quercus Brantii Lindl. Vaginal Douche Versus Clotrimazole on Vaginal Candidiasis: A Randomized Clinical TrialTHR1 mediates GCN4 and CDC4 to link morphogenesis with nutrient sensing and the stress response in Candida albicans
P2860
Q26752938-A0D25B74-B5D5-4476-A737-62FB225F2A2DQ26776056-9A3A950D-9563-4702-9089-580C192E17F3Q26864461-75A4C7E1-C92E-466A-9750-63EEC5E14B58Q28077299-F164C924-939F-4F5D-84D2-22A1EDF8649DQ28552602-C406E1FA-32B9-4642-BFE2-D35185595B21Q33786868-DFB1E91B-4BD6-45F7-B704-B3FD5152BF48Q35439961-DD61A348-2AD1-4F87-BD6F-180BEBBBF0F7Q35650359-6A3191F5-559F-4E27-96AD-FB0C6E5955AEQ35734134-F22B7A20-FC89-41A4-A782-0C57E85929D9Q35840387-F5EBCBED-4017-48E9-BBCD-199148291359Q36080619-55ED8081-FFD0-4075-AA97-2E0F9484C89EQ36231575-C917BCC2-560C-45D2-AEB4-776DD97542C9Q37062344-BF59DC87-0E7D-4ED4-9EB7-ED2E6809CD40Q37736301-D5F9EC7A-747F-4C42-9FB8-7F6F16F3ADD1Q38708925-1FA54B21-BB9F-4018-B2F6-597B9FD2575EQ40045591-DB9C7C47-0732-4D57-8394-2F93BCA36941Q40160325-1CC28D82-2C00-43D2-A26C-A323967DDED0Q40184093-F66AE94D-AF02-41D5-8E5B-0D21AA738FB6Q47138065-681F7505-5D48-4628-9192-9D532664BE95Q47549427-070B9F60-102D-4BC6-B8C4-BE3289077922Q47953950-1EB0727E-A823-4F65-9244-54603FC19567Q48094804-0B33607E-3421-4456-8387-8B652235F650Q48422773-CE706CAA-870C-4117-AD9C-8786E1C1FC8AQ55004750-D7D6859C-8819-458E-91B0-2C4BDED5B7B3Q55106189-D3634AFB-65E3-4A81-B199-006A028DBBB2Q57126579-D0A20ACE-0CAD-4FA0-9EA5-36CBF4193634Q57471204-8DA94DC7-59FC-49D4-8596-2DDE2E756D69
P2860
Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects.
@en
type
label
Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects.
@en
prefLabel
Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects.
@en
P2860
P356
P1476
Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects.
@en
P2093
P2860
P304
P356
10.1111/1471-0528.12994
P577
2014-07-23T00:00:00Z